Strategies to Assist Patients With Treatment Decision Making and Managing Adverse Events of Multiple Myeloma
  • CE

In this archived CE-certified webcast of a live meeting workshop, Beth Faiman, PhD, MSN, APRN-BC, AOCN, presents optimal nursing strategies for the management of patients with multiple myeloma.
Beth Faiman, PhD, MSN, APRN-BC, AOCN
Program Director
Joseph Tariman Headshot
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN
Program Director
Registered Nurses: 1.0 Nursing contact hour
Released: January 6, 2020 Expiration: January 5, 2021

Learning Objectives

Upon completion of this activity, participants should be able to:
  • Provide patient-focused education on the available clinical data and new therapeutic options for the individualized treatment of MM
  • Discuss with patients the available data and rationale for using monoclonal antibodies as well as new-generation immunomodulatory agents and proteasome inhibitors for individual patients with MM
  • Evaluate individualized treatment strategies for elderly patients through consideration of the available clinical data as well as risk assessment, comorbidities, and patient preferences
  • Develop a proactive management plan for adverse events associated with recently approved agents and novel combinations used to treat MM
  • Manage the physical, emotional, and social challenges experienced by patients diagnosed with MM through all stages of their disease

Information on this Educational Activity

The Annenberg Center assesses conflict of interest with its instructors, planners, managers, and other individuals who are in a position to control the content of CME/CE activities. All relevant conflicts of interest that are identified are thoroughly vetted by the Annenberg Center for fair balance, scientific objectivity of studies utilized in this activity, and patient care recommendations. The Annenberg Center is committed to providing its learners with high-quality CME/CE activities and related materials that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest.

The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME/CE activity:

Program Director

Beth Faiman, PhD, MSN, APRN-BC, AOCN

Nurse Practitioner
Cleveland Clinic Taussig Cancer Institute
Cleveland, Ohio

Beth Faiman, PhD, MSN, APRN-BC, AOCN, has no significant financial conflicts to disclose.
Joseph D. Tariman, PhD, RN, ANP-BC, FAAN

Assistant Professor, Nursing
Associate Co-Director, Doctor of Nursing Practice Program
DePaul University
Chicago, Illinois

Joseph D. Tariman, PhD, RN, ANP-BC, FAAN, has no significant financial conflicts to disclose.

Staff

Terrence Fagan

Associate Scientific Director

Terrence Fagan has no relevant conflicts of interest to report.
Timothy A. Quill, PhD

Associate Director, Scientific Services

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.
Gordon Kelley

Senior Clinical Editor

Gordon Kelley has no relevant conflicts of interest to report.
Kevin Obholz, PhD

Senior Director, Educational Strategy

Kevin Obholz, PhD, has no relevant conflicts of interest to report.
June Wasserstrom

Director, CME Program Development

June Wasserstrom has no relevant conflicts of interest to report.
Tina B. Stacy, PharmD, FACEHP, BCOP, CHCP

Executive Vice President, Educational Strategy
General Manager, Oncology

Tina B. Stacy, PharmD, FACEHP, BCOP, CHCP, has no relevant conflicts of interest to report.

The PIM planners and managers have nothing to disclose.

Charles E. Willis, Director of Continuing Education; Amanda Sewell, MBA, Manager of Continuing Education and Melissa Velasquez, Accreditation Specialist from the Annenberg Center for Health Sciences at Eisenhower have no relevant commercial relationships to disclose.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The Annenberg Center, Postgraduate Institute for Medicine (PIM), Clinical Care Options, and activity supporters do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the Annenberg Center, PIM, Clinical Care Options, and activity supporters. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Target Audience

This program is intended for oncology nurses and other healthcare providers who care for patients with multiple myeloma.

Goal

The goal of this activity is to improve oncology nurses’ ability to educate and optimally care for patients with multiple myeloma.

Nursing Continuing Education

Accreditation Statement

Annenberg Center for Health Sciences is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

Credit Designation

1.0 contact hour may be earned for successful completion of this activity.

Program Medium

This program has been made available online.

Instructions for Credit

Participation in this self-study activity should be completed in approximately 1.0 hours. To successfully complete this activity and receive credit, participants must follow these steps during the period from January 06, 2020, through January 05, 2021:

1. Register online at http://www.clinicaloptions.com.
2. Read the target audience, learning objectives, and faculty disclosures.
3. Study the educational activity online or printed out.
4. Submit answers to the posttest questions and evaluation questions online.

You must receive a test score of at least 65% and respond to all evaluation questions to receive a certificate. After submitting the evaluation, you may access your online certificate by selecting the certificate link on the posttest confirmation page. Records of all CME/CE activities completed can be found on the "CME/CE Manager" page. There are no costs/fees for this activity.

Related Content

In this Clinical Care Options (CCO) expert commentary, Sagar Lonial, MD, provides his thoughts on the key studies in myeloma presented at ASH 2019

Sagar Lonial, MD Released: February 26, 2020

From Clinical Care Options (CCO), read expert answers to key questions from community practitioners on optimizing CAR T-cell therapy

Michael R. Bishop, MD Jae H. Park, MD person default Joshua P. Sasine, MD, PhD Released: February 25, 2020

Eunice S. Wang, MD, provides expert insights on a novel chemotherapy/immunotherapy combination for treating ALL in this commentary from Clinical Care Options (CCO)

Eunice S. Wang, MD Released: February 25, 2020

Ian W. Flinn, MD, PhD, answers frequently asked questions on use of BTK inhibitors in patients with hematologic malignancies in this CCO commentary

Ian W. Flinn, MD, PhD Released: February 21, 2020
Provided by the Annenberg Center for Health Sciences at Eisenhower
ACHS Logo

Annenberg Center for Health Sciences at Eisenhower
39000 Bob Hope Dr
Dinah Shore Bldg.
Rancho Mirage, CA 92270

Alma Perez, Accreditation Specialist
(760) 773-4506
(760) 773-4550 (Fax)
ce@annenberg.net
http://www.annenberg.net/

Supported by educational grants from
Amgen
Celgene Corporation

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Welcome to the CCO site.

You are accessing CCO's educational content today as a Guest user.

If you would like to continue with free, full access to the CCO Web sites, including free CME/CE credits, please click the button below.

Continue

More info

CCO’s educational programs are available completely free of charge on the ClinicalOptions.com, inPractice.com, and inPracticeAfrica.com Web sites. Certain features and functions are restricted for Guest users. By consenting to become a full member, you are eligible to receive CME/CE credit or participation certificates from certified activities, to register for CCO’s free live meetings and webinars, and to receive CCO’s email newsletters alerting you to new content. You can unsubscribe from our emails at any time. CCO strictly protects the privacy of our members, according to our privacy policy.

A confirmation email will be sent to . Not You?